Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 71Myelodysplastic Syndromes 71Leukemia 68Lymphoma 65Leukemia, Myeloid, Acute 63Leukemia, Lymphocytic, Chronic, B-Cell 61Lymphoma, Non-Hodgkin 56Hodgkin Disease 51Multiple Myeloma 45Leukemia, Myeloid, Chronic-Phase 44Lymphoma, Follicular 43Lymphoma, Mantle-Cell 42Lymphoma, Large B-Cell, Diffuse 42Leukemia, Myeloid, Accelerated Phase 42Lymphoma, B-Cell, Marginal Zone 41Myeloproliferative Disorders 40Burkitt Lymphoma 40Lymphoma, Large-Cell, Immunoblastic 35Neoplasms, Plasma Cell 34Congenital Abnormalities 31Leukemia, Myelomonocytic, Chronic 29Blast Crisis 29Dendritic Cell Sarcoma, Interdigitating 28Primary Myelofibrosis 26Recurrence 25Lymphoma, T-Cell, Cutaneous 23Anemia, Refractory, with Excess of Blasts 23Myelodysplastic-Myeloproliferative Diseases 22Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 22Graft vs Host Disease 22

Interventions

liposomal amphotericin B 1Voriconazole 1ProMune 1Lymphatic Irradiation 1Levofloxacin 1Fluconazole 1Cyclosporine 1Antilymphocyte Serum 1Amphotericin B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mycoses × Antilymphocyte Serum × Lymphoid × Clear all
NCT00896493 2023-05-11

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Stanford University

Phase 2 Completed
38 enrolled 21 charts
DermatologicLymphoid

Lymphoma, Non-Hodgkin, Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡